Equities

Molina Healthcare Inc

Molina Healthcare Inc

Actions
Health CareHealth Care Providers
  • Price (USD)290.79
  • Today's Change-5.28 / -1.78%
  • Shares traded708.30k
  • 1 Year change-20.30%
  • Beta0.5414
Data delayed at least 15 minutes, as of Nov 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform6
Hold9
Sell1
Strong Sell0

Share price forecast in USD

The 14 analysts offering 12 month price targets for Molina Healthcare Inc have a median target of 376.00, with a high estimate of 406.00 and a low estimate of 309.00. The median estimate represents a 29.30% increase from the last price of 290.79.
High39.6%406.00
Med29.3%376.00
Low6.3%309.00

Earnings history & estimates in USD

On Oct 23, 2024, Molina Healthcare Inc reported 3rd quarter 2024 earnings of 6.01 per share. This result was in line with the consensus of the 15 analysts following the company and exceeded last year's 3rd quarter results by 19.01%.
The next earnings announcement is expected on Feb 05, 2025.
Average growth rate+5.60%
Molina Healthcare Inc reported annual 2023 earnings of 20.88 per share on Feb 07, 2024.
Average growth rate+17.00%
More ▼

Revenue history & estimates in USD

Molina Healthcare, Inc. had 3rd quarter 2024 revenues of 10.34bn. This bettered the 9.91bn consensus of the 12 analysts covering the company. This was 26.89% above the prior year's 3rd quarter results.
Average growth rate+4.94%
Molina Healthcare, Inc. had revenues for the full year 2023 of 34.07bn. This was 6.56% above the prior year's results.
Average growth rate+20.02%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.